Analgesics in Finland

Analgesics in Finland

  • October 2017 •
  • 19 pages •
  • Report ID: 165058
The mature analgesics category saw some signs of revival during 2016 and 2017. Better value growth was achieved by two new categories becoming available in OTC form in late 2015-2016. Adult naproxen and triptans obtained LVI status (an OTC product that requires consultation with a pharmacist). These status changes had a positive impact on overall sales of analgesics. OTC naproxen and triptans are offered for emergency use, and therefore they have notably higher unit prices than the same brands p...

Euromonitor International’s Analgesics in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=Finland Industry=OTC ParentIndustry=LifeSciences Date=201710 Topic=Demand Publisher=EuromonitorInternational Price=1000